In this position, Mr. Klarl will be responsible for the sales efforts of Titan Spine’s line of specialized Endoskeleton interbody fusion devices. He joins Titan Spine from Spinal Kinetics, where he was responsible for a sales increase of the group’s M6 Cervical and Lumbar Artificial Discs.
More Articles on Orthopedic Devices:
International Journal of Nanosystems Publishes Paper Penned by NuOrtho’s Chief Clinical Officer
LDR Receives Approvable Letter From FDA for Mobi-C Device
Misonix Q1 Revenue Increases 42% to $4.6M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
